Launch week offerEnds in00h00m00s

annual Promonthly Pro

Toni Choueiri

Director, Lank Center for Genitourinary Oncology

Dana-Farber Cancer Institute

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Articles (12)

Year:

2026

Year:

2026

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (12)

Frede Donskov

University of Southern Denmark

DENMARK

View details

Amanda Garza

Senior Scientist

Dana-Farber Cancer Institute

UNITED STATES

View details

Adam Dicker

Professor & Chair

Thomas Jefferson University

UNITED STATES

View details

Kate Lawrenson

University of Texas Health Science Center at San Antonio

UNITED STATES

View details

Chih-Yuan Hsu

Research Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Haiteng Deng

Professor/Director

Tsinghua University

CHINA

View details

Eddy Saad

Dana-Farber Cancer Institute

UNITED STATES

View details

Bernadett Szabados

Barts Cancer Institute

UNITED KINGDOM

View details

Sandor Spisak

Head of Laboratory/Research Associate Professor

Research Centre for Natural Sciences

HUNGARY

View details

Bradley McGregor

Harvard University

UNITED STATES

View details

Amin Nassar

Yale University

UNITED STATES

View details

Liliana Ascione

Dana-Farber Cancer Institute

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Toni Choueiri

Research Interests

Make your next move.

Explore related searches

Articles (12)

A Mitochondrial Plasma Proteomic Signature Identifies Metastatic Chromophobe Renal Cell Carcinoma

Single-cell epigenetic profiling reveals a tumor-intrinsic interferon response program in ccRCC tied to poor prognosis and BAP1 loss

Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma

Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

Epigenomic charting and functional annotation of risk loci in renal cell carcinoma

Access to definitive treatment and survival for intermediate-risk and high-risk prostate cancer at hospital systems serving health disparity populations

Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma

Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma – Authors' reply

Perioperative immunotherapy for renal cell carcinoma: looking beyond the data

The Natural History of Renal-Cell Carcinoma with Sarcomatoid Differentiation, a Stage-by-Stage Analysis

CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).

Collaborators (12)

Frede Donskov

Amanda Garza

Adam Dicker

Kate Lawrenson

Chih-Yuan Hsu

Haiteng Deng

Eddy Saad

Bernadett Szabados

Sandor Spisak

Bradley McGregor

Amin Nassar

Liliana Ascione

Make your next move.